Abundance Wealth Counselors’s 9 Meters Biopharma NMTR Stock Holding History

Abundance Wealth Counselors’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20	Closed	–	–	368
2021 Q1	$0	Buy	+20	New	+$615	﹤0.01%	376

Other funds holding NMTR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Abundance Wealth Counselors's NMTR Position: Q2 2021 in Review

Abundance Wealth Counselors sold out of 9 Meters Biopharma (NMTR) in Q2 2021, closing a stake of 20 shares.

Abundance Wealth Counselors first reported a position in NMTR in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 99 funds tracked by Wall St. Rank hold NMTR as of Q2 2021.

Abundance Wealth Counselors reported no remaining 9 Meters Biopharma position as of Q2 2021 after selling out during the quarter.
Abundance Wealth Counselors sold 20 9 Meters Biopharma shares in Q2 2021.
Abundance Wealth Counselors first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 1 quarter.
Abundance Wealth Counselors's 9 Meters Biopharma position peaked at $0 in Q1 2021.
99 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2021.

Based on Abundance Wealth Counselors's 13F filing for Q2 2021, filed 21 Jul 2021.